IgG N-Glycosylation Is Altered in Coronary Artery Disease
Coronary artery disease (CAD) is the most common cardiovascular disease (CVD), and previous studies have shown a significant association between N-glycosylation, a highly regulated posttranslational modification, and the development of atherosclerotic plaques. Our aim was to determine whether the N-...
Main Authors: | Barbara Radovani, Frano Vučković, Aldo P. Maggioni, Ele Ferrannini, Gordan Lauc, Ivan Gudelj |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/2/375 |
Similar Items
-
N-Glycosylation and Inflammation; the Not-So-Sweet Relation
by: Barbara Radovani, et al.
Published: (2022-06-01) -
The <i>N</i>-Glycosylation of Total Plasma Proteins and IgG in Atrial Fibrillation
by: Branimir Plavša, et al.
Published: (2023-03-01) -
Baseline IgG-Fc N-glycosylation profile is associated with long-term outcome in a cohort of early inflammatory arthritis patients
by: Thomas Sénard, et al.
Published: (2022-08-01) -
Altered glycosylation profiles of serum IgG in Takayasu arteritis
by: Lingyu Liu, et al.
Published: (2023-02-01) -
IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers
by: Benjamin S. Haslund-Gourley, et al.
Published: (2023-03-01)